Cargando…

Response Prediction to Neoadjuvant Chemotherapy: Comparison between Pre-Therapeutic Gene Expression Profiles and In Vitro Chemosensitivity Assay

Although the use of (neo-)adjuvant chemotherapy in breast cancer patients has resulted in improved outcome, not all patients benefit equally. We have evaluated the utility of an in vitro chemosensitivity assay in predicting response to neoadjuvant chemotherapy. Pre-therapeutic biopsies were obtained...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singer, Christian F., Klinglmüller, Florian, Stratmann, Rembert, Staudigl, Christine, Fink-Retter, Anneliese, Gschwantler, Daphne, Helmy, Samir, Pfeiler, Georg, Dressler, Anne Catharina, Sartori, Christian, Bilban, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691196/ https://www.ncbi.nlm.nih.gov/pubmed/23826101 http://dx.doi.org/10.1371/journal.pone.0066573

Ejemplares similares

Prognostic Relevance of Pretherapeutic Gamma-Glutamyltransferase in Patients with Primary Metastatic Breast Cancer
por: Staudigl, Christine, et al.
Publicado: (2015)

Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in Austria
por: Deutschmann, Christine, et al.
Publicado: (2022)

Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect”
por: Staudigl, Christine, et al.
Publicado: (2016)

Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients
por: Singer, Christian F., et al.
Publicado: (2019)

Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriers
por: Rieder, Viktoria, et al.
Publicado: (2015)

Residual fibroglandular breast tissue after mastectomy is associated with an increased risk of a local recurrence or a new primary breast cancer"
por: Deutschmann, Christine, et al.
Publicado: (2023)

Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool
por: Tea, Muy-Kheng M., et al.
Publicado: (2018)

Cadherin-11 expression is upregulated in invasive human breast cancer
por: Pohlodek, Kamil, et al.
Publicado: (2016)

Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer
por: Michalski, C W, et al.
Publicado: (2008)

HER Specific TKIs Exert Their Antineoplastic Effects on Breast Cancer Cell Lines through the Involvement of STAT5 and JNK
por: Gschwantler-Kaulich, Daphne, et al.
Publicado: (2016)

Chick Embryo Assay as Chemosensitivity Test for Malignant Glioma
por: Shoin, Katsuo, et al.
Publicado: (1991)

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer
por: Murphy, Neal, et al.
Publicado: (2022)

Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro
por: Gschwantler-Kaulich, Daphne, et al.
Publicado: (2017)

Comparison of assays used for in vitro chemosensitivity testing of human tumours.
por: Salmon, S. E., et al.
Publicado: (1984)

Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma
por: Kim, Dae Won, et al.
Publicado: (2023)

Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay
por: Knight, Louise A, et al.
Publicado: (2009)

CD133 Is a Useful Surrogate Marker for Predicting Chemosensitivity to Neoadjuvant Chemotherapy in Breast Cancer
por: Aomatsu, Naoki, et al.
Publicado: (2012)

Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy
por: Qian, Yi, et al.
Publicado: (2018)

Chemosensitivity testing of small cell lung cancer using the MTT assay.
por: Campling, B. G., et al.
Publicado: (1991)

A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy.
por: Wilson, J. K., et al.
Publicado: (1990)

Organ-Tumor-on-a-Chip for Chemosensitivity Assay: A Critical Review
por: Kashaninejad, Navid, et al.
Publicado: (2016)

Tumor Chemosensitivity Assays Are Helpful for Personalized Cytotoxic Treatments in Cancer Patients
por: Ulukaya, Engin, et al.
Publicado: (2021)

Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib
por: Rohr-Udilova, Nataliya, et al.
Publicado: (2017)

Patient satisfaction after breast cancer surgery: A prospective clinical trial
por: Leser, Carmen, et al.
Publicado: (2020)

Altered Expression of RB and pRB in Tissue Arrays of Primary Breast Cancers and Matched Axillary Lymph Node Metastases
por: Leser, Carmen, et al.
Publicado: (2022)

Liver function indicators in patients with breast cancer before and after detection of hepatic metastases-a retrospective study
por: Leser, Carmen, et al.
Publicado: (2023)

Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia.
por: Pieters, R., et al.
Publicado: (1989)

Impact of Immunohistochemistry-Based Molecular Subtype on Chemosensitivity and Survival in Patients with Breast Cancer Following Neoadjuvant Chemotherapy
por: Yoo, Changhoon, et al.
Publicado: (2012)

Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration
por: Jiang, Xiu-Feng, et al.
Publicado: (2022)

Use of polysaccharide hemostatic agent (HaemoCer™) in breast cancer surgery to reduce postoperative complications: A randomised controlled trial
por: Falcone, Veronica, et al.
Publicado: (2022)

Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia.
por: Sargent, J. M., et al.
Publicado: (1989)

Chemosensitivity testing of human lung cancer cell lines using the MTT assay.
por: Carmichael, J., et al.
Publicado: (1988)

A comparison of three assays used for the in vitro chemosensitivity testing of human tumours.
por: Wilson, A. P., et al.
Publicado: (1984)

Chemosensitivity of human head and neck cancer xenografts in the clonogenic assay and in nude mice.
por: Boerrigter, G. H., et al.
Publicado: (1986)

An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia.
por: Bosanquet, A. G., et al.
Publicado: (1983)

Chemosensitivity of Anaplastic Thyroid Cancer Based on a Histoculture Drug Response Assay
por: Uruno, Takashi, et al.
Publicado: (2015)

Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder
por: van den Tempel, Nathalie, et al.
Publicado: (2018)

Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
por: Sharma, Sanjay, et al.
Publicado: (2003)

Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response
por: Zhou, Qing, et al.
Publicado: (2022)

Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in Hispanic breast cancer patients following neoadjuvant chemotherapy
por: Gómez, Rodolfo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cdtvaj76stk7h9890v08r2is5o